Only 59 exhibited a significant RhoA-p115 complex GDP/GTP exchange inhibition potential (IC50 187 μM, 50.5% inhibition) in the Biacore assay, thus it could have a potential for treating high blood pressure (Olivon et al., 2018). Here, RHOA is linked to hypertensive disorder.